Abstract
Atherosclerosis is an underlying cause of a broad array of cardiovascular diseases characterized by plaques, arterial wall thickening initiated by hyperlipidemia, pro-inflammatory signals, endothelial dysfunction and the influx of inflammatory cells. By still incompletely characterized mechanisms, these plaques can destabilize or erode, leading to thrombosis and blood vessel occlusion and becomes clinically manifest as angina pectoris, myocardial infarction (MI) or stroke.Among the several blood cell types that are involved in the development of atherosclerosis, the role of platelets during the thrombotic occlusion of ruptured or eroded plaques is well established and clinically exploited as evident by the extensive use of platelet inhibitors. However, there is increasing evidence that platelets are also involved in the earlier stages of atheroma development by exhibiting pro-inflammatory activities. The scope of this review is to describe the role of platelets in the initiation and propagation stages of atherosclerosis and beyond; in atherothrombotic complications.
Original language | English |
---|---|
Pages (from-to) | 132-141 |
Number of pages | 10 |
Journal | Atherosclerosis |
Volume | 319 |
DOIs | |
Publication status | Published - 1 Feb 2021 |
Keywords
- atherosclerosis
- inflammation
- monocyte
- myocardial infarction
- neutrophil
- platelets
- Myocardial infarction
- Monocyte
- Atherosclerosis
- Inflammation
- Neutrophil
- Platelets